Key features of Ebola hemorrhagic fever: A review

Asian Pacific Journal of Tropical Biomedicine

Volumn 4, Issue 11, 2014, Pages 841-844

  Sousa, Zulane Lima ^a  

^a DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

Ebola hemorrhagic fever; Ebola outbreak; Ebola virus; Ebola virus infection

Indexed keywords

FAVIPIRAVIR; INTERFERON; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NEUTRALIZING MONOCLONAL ANTIBODY; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AIRBORNE INFECTION; BAT; BLOOD VESSEL PERMEABILITY; BODY FLUID; CLINICAL FEATURE; CONJUNCTIVA DISEASE; CONJUNCTIVAL INFECTION; CONTACT EXAMINATION; CONVALESCENCE; CYTOKINE PRODUCTION; DISEASE CARRIER; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; EARLY DIAGNOSIS; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; FRUIT BAT; HUMAN; IMMUNE EVASION; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE; MACROPHAGE ACTIVATION; MACULOPAPULAR RASH; MEDICAL HISTORY; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; PROTECTIVE EQUIPMENT; REVIEW; SHOCK; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EBOLA VIRUS;

EID: 84922709628     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.12980/APJTB.4.201414B420     Document Type: Article

References (21)

1. Bausch DG, Bangura J, Garry RF, Goba A, Grant DS, Jacquerioz FA, et al. A tribute to Sheik Humarr Khan and all the healthcare workers in West Africa who have sacrificed in the fight against Ebola virus disease: Mae we hush. Antiviral Res 2014; 111C: 33-35.
2. World Health Organization. WHO: Ebola response roadmap update. Geneva: World Health Organization; 2014. [Online] Available from: http://apps.who.int/iris/bitstream/10665/135029/1/roadmapupdate26sept14_eng.pdf?ua=1 [Accessed on 27th September, 2014]
3. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun 2014; doi: 10.1016/j.jaut.2014.09.001.
4. Hoenen T, Groseth A, Falzarano D, Feldmann H. Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol Med 2006; 12: 206-215.
5. Le Guenno B, Galabru J. Ebola virus. Bull Inst Pasteur 1997; 95: 73-83.
6. Brown KS, Silaghi A, Feldmann H. Ebola virus. In: Mahy BWJ, van Regenmortel MHV, editors. Encyclopedia of virology. 3rd ed. Vol 2. Oxford: Elsevier; 2008, p. 57-65.
7. Groseth A, Feldmann H, Strong JE. The ecology of Ebola virus. Trends Microbiol 2007; 15: 408-416.
8. Pourrut X, Kumulungui B, Wittmann T, Moussavou G, Délicat A, Yaba P, et al. The natural history of Ebola virus in Africa. Microbes Infect 2005; 7: 1005-1014.
9. Ki M. What do we really fear? The epidemiological characteristics of Ebola and our preparedness. Epidemiol Health 2014; doi: 10.4178/epih/e2014014. eCollection 2014.
10. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, et al. Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites. J Infect Dis 2007; 196(Suppl 2): S142-S147.
11. Colebunders R, Borchert M. Ebola hemorrhagic fever-a review. J Infect 2000; 40: 16-20.
12. Feldmann H, Wahl-Jensen V, Jones SM, Ströher U. Ebola virus ecology: a continuing mystery. Trends Microbiol 2004; 12: 433-437.
13. Murphy FA, Peters CJ. Ebola virus: where does it come from and where is it going? In: Krause RM, editor. Emerging infections. New York: Academic Press; 1998, p. 375-410.
14. Feldmann H, Geisbert TW. Ebola hemorrhagic fever. Lancet 2011; 377: 849-862.
15. Takada A, Kawaoka Y. The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol 2001; 9: 506-511.
16. Heymann DL, Barakamfitiye D, Szczeniowski M, Muyembe-Tamfum JJ, Bele O, Rodier G. Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179(Suppl 1): S283-S286.
17. Oestereich L, Lüdtke A, Wurr S, Rieger T, Muñoz-Fontela C, Günther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 2014; 105: 17-21.
18. Chepurnov AA, Bakulina LF, Dadaeva AA, Ustinova EN, Chepurnova TS, Baker JR Jr. Inactivation of Ebola virus with a surfactant nanoemulsion. Acta Trop 2003; 87: 315-320.
19. Sullivan N, Yang ZY, Nabel GJ. Ebola virus pathogenesis: implications for vaccines and therapies. J Virol 2003; 77: 9733-9737.
20. Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK, et al. The international Ebola emergency. N Engl J Med 2014; 371: 1180-1183.
21. Tambo E, Ugwu EC, Ngogang JY. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Infect Dis Poverty 2014; 3: 29.